At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on May 24th, 2022 | 10:20 CEST
Monkeypox: risks and opportunities - Bavarian Nordic, Desert Gold, Varta
Supply chain problems, energy price chaos and now monkeypox? The list of disturbing news never ends. Investors need to keep a cool head in this market phase. Which construction sites are a permanent burden on the markets, where are only isolated problems still looming, and where are there possibly even surprising potholes? We have taken a close look at three stocks from different sectors. Let's go straight to the monkeypox!
Read
Commented by Nico Popp on May 23rd, 2022 | 10:36 CEST
Long on war with Rheinmetall, Defense Metals, BYD
Armaments are booming! As early as 2021, global military spending reached USD 2.113 trillion, according to the Stockholm-based peace research institute SIPRI. That was followed by Russia's invasion of Ukraine and the West's surprisingly united response. Currently, numerous weapons are arriving in Ukraine from many countries around the world. A high-ranking Russian military observer recently even said on TV that almost the whole world was against Russia. At the same time, Sweden and Finland are striving to join NATO. Additional billions for the armament sector are inevitable. We present three stocks that are booming.
Read
Commented by Nico Popp on May 20th, 2022 | 11:35 CEST
Capital increase? What you need to know! TUI, Triumph Gold, Steinhoff
To be successful as a company, you need not only motivated employees, functioning machines and brilliant ideas, but also capital. Investments are the cornerstone for growth and success on the stock market. But why are companies that raise "fresh money" on the market regularly punished? Is it possibly related to communication and how the funds are used? We take a closer look at three stocks.
Read
Commented by Nico Popp on May 19th, 2022 | 10:52 CEST
Quick percentages? We have the shares: Plug Power, Erin Ventures, Varta
Fallen angels are almost an investment category of their own on the stock market - after all, even the most tired crutch on the floor usually completes a rebound. But today, in particular, investors should take a close look: Where is the proverbial "dead cat bounce" looming, where is it possible that things will go significantly up again, and where does a historic opportunity beckon? To answer these questions, investors need to go into detail - and develop a feel for sentiment.
Read
Commented by Nico Popp on May 18th, 2022 | 12:53 CEST
Big percentages thanks to platform strategy: Amazon.com, Defence Therapeutics, Nordex
A central principle of the platform economy is to bring together different user groups and thus create synergies. What sounds a bit dry quickly becomes interesting, especially from an investor's point of view. For example, when different car models are based on one and the same platform, or when several diseases can be effectively combated thanks to one and the same technology. The unique aspect for investors: If these synergies come to fruition and a business succeeds in scaling, high returns are possible. We cite three stocks as examples.
Read
Commented by Nico Popp on May 17th, 2022 | 09:54 CEST
Alzheimer's share? Ask the CEO! Valneva, NervGen Pharma, Bayer
High blood pressure, diabetes, stroke and Alzheimer's disease are scourges of our time. As people in industrialized countries grow older, it becomes increasingly likely that they will also suffer from one of these diseases. While there is likely to be a genetic predisposition for all of the ailments mentioned, lifestyle also plays a role. Lack of exercise and obesity often leads first to high blood pressure, then to diabetes, and ultimately to even worse conditions. In the event of a pandemic, all people with such pre-existing conditions belong to a high-risk group. Reason enough to take a closer look at stocks related to these issues and ask how investors can profit.
Read
Commented by Nico Popp on May 16th, 2022 | 12:48 CEST
Future Tech check: BASF, Meta Materials, BYD, Rock Tech Lithium
What will drive share prices in the future is more uncertain than ever. The sword of Damocles of the recession is currently hovering over many future topics. But should long-term investors be driven by fear of recession? On the contrary! Now is the best time to consider investments for the future. The good thing is that thorough due diligence can pay off twice over. First, it increases the chances of hitting the bull's eye, and second, the prices may even suit investors. We take a closer look at three shares!
Read
Commented by Nico Popp on May 9th, 2022 | 12:50 CEST
Progress at any price! Mercedes-Benz, BrainChip, Varta
People want mobility. We cannot convey a future full of renunciation. Instead, sustainable innovations must be made attractive. What sounds like squaring the circle from today's perspective can become a well-rounded affair in the long term - if ideas meet technology. We present three stocks related to the future of mobility and explain where investors can also see the potential.
Read
Commented by Nico Popp on May 5th, 2022 | 11:52 CEST
Biotech-Investments also work conservatively: BioNTech, XPhyto, Valneva
Biotech stocks are often seen as all-or-nothing investments - either a bet works out, or the companies disappear into oblivion. But innovative companies in the pharmaceutical and biotech sectors do not always operate in just one area. They are not always spectacular projects that are dependent on approval procedures. We outline the investment opportunities around three well-known biotech stocks.
Read
Commented by Nico Popp on May 4th, 2022 | 13:05 CEST
Attention, special situation! BASF, Barsele Minerals, Amazon
Old Economy? Tech stocks? Or special situations? Investors find different ways to stay invested during difficult market phases. It is not for nothing that the motto "Time in the market beats timing in the market" exists. Nevertheless, it makes sense right now to increase the equity quota only selectively. We will outline which stocks could be considered for this using three companies as examples.
Read